These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15049403)

  • 1. Intravenous desensitization to allopurinol in a heart transplant patient with gout.
    Schumacher MJ; Copeland JG
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):374-6. PubMed ID: 15049403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.
    Walz-LeBlanc BA; Reynolds WJ; MacFadden DK
    Arthritis Rheum; 1991 Oct; 34(10):1329-31. PubMed ID: 1930322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of desensitization to allopurinol following cutaneous reactions.
    Fam AG; Dunne SM; Iazzetta J; Paton TW
    Arthritis Rheum; 2001 Jan; 44(1):231-8. PubMed ID: 11212165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization to allopurinol in patients with gout and cutaneous reactions.
    Fam AG; Lewtas J; Stein J; Paton TW
    Am J Med; 1992 Sep; 93(3):299-302. PubMed ID: 1388001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ; Whallett A; Zaphiropoulos G
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypersensitivity to allopurinol. Efficacy of a desensitizing protocol in 3 cases].
    Domínguez Ortega J; Trindade C; Alonso Llamazares A; Castellano Bravo A; Cimarra Alvárez-Lovel M; Martínez-Cócera C
    An Med Interna; 2001 Jan; 18(1):27-8. PubMed ID: 11387841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful desensitization of a fixed drug eruption caused by allopurinol.
    Umpiérrez A; Cuesta-Herranz J; De Las Heras M; Lluch-Bernal M; Figueredo E; Sastre J
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):286-7. PubMed ID: 9500766
    [No Abstract]   [Full Text] [Related]  

  • 8. Desensitization to allopurinol in a patient with previous failed desensitization.
    Tanna SB; Barnes JF; Seth SK
    Ann Pharmacother; 1999 Nov; 33(11):1180-3. PubMed ID: 10573316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [De-sensitization to allopurinol in a patient with tophi gout].
    López-Rocha EG; Hernández-Montoya G; Rodríguez-Pesina AH; Rodríguez-Mireles KA
    Rev Alerg Mex; 2018; 65(3):316-320. PubMed ID: 30176211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM; Sathischandra H; Jayamanne SF; de Silva HJ
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E
    Ugeskr Laeger; 1998 Feb; 160(8):1179-80. PubMed ID: 9492630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules.
    Calogiuri G; Nettis E; Di Leo E; Foti C; Ferrannini A; Butani L
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):19-28. PubMed ID: 23092365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal liver necrosis due to allopurinol].
    Pereira S; Almeida J; Silva AO; Quintas M; Candeias O; Freitas F
    Acta Med Port; 1998 Dec; 11(12):1141-4. PubMed ID: 10192993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol.
    Calogiuri GF; Satriano F; Muratore L; Valacca A; Nettis E; Di Leo E; Vacca A
    J Investig Allergol Clin Immunol; 2009; 19(4):333-4. PubMed ID: 19639739
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
    Fajt M; Petrov A
    Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol hypersensitivity in a patient with severe, chronic, tophaceous gout.
    Webster E; Panush RS
    Arthritis Rheum; 1985 Jun; 28(6):707-9. PubMed ID: 4004980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.